⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6900438 | 1.00 | — | — | |
| SCHEMBL989373 | 1.00 | — | — | |
| SCHEMBL5376743 | 1.00 | — | — | |
| SCHEMBL7052054 | 1.00 | — | — | |
| SCHEMBL6269441 | 0.95 | ALDH1A1 (0.36) | — | |
| SCHEMBL9718773 | 0.95 | ALDH1A1 (0.36) | — | |
| SCHEMBL12079166 | 0.95 | ALDH1A1 (0.36) | — | |
| SCHEMBL5881101 | 0.95 | — | — | |
| SCHEMBL13891938 | 0.95 | ALDH1A1 (0.36) | — | |
| SCHEMBL10715035 | 0.91 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-1261354-A | — | — | None | — | — | JP | disclosed |
| WO-2024129037-A1 | EFFICIENT OXIDATIVE CHLORINATION AND BROMINATION METHOD OF OLEFINS WITH SELECTFLUOR AND TBAX (CL, BR) | ATATÜRK ÜNİVERSİTESİ FİKRİ MÜLKİYET HAKLARI KOORDİNATÖRLÜĞÜ DÖNER SERMAYE İŞLETMESİ (TR) | 2024-06-20 | — | — | WO | disclosed |
| US-20170315079-A1 | RARE EARTH METAL INCORPORATED ZEOLITE MODIFIED ELECTRODES FOR DETECTION AND QUANTIFICATION OF HEAVY METAL IONS IN AQUEOUS SOLUTION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2017-11-02 | — | — | US | disclosed |
| US-20090306134-A1 | Muscarinic receptor antagonists | THERAVANCE BIOPHARMA R&D IP, LLC | 2009-12-10 | — | — | US | disclosed |
| US-20090306134-A1 | Muscarinic receptor antagonists | THERAVANCE BIOPHARMA R&D IP, LLC | 2009-12-10 | — | — | US | disclosed |
| EP-1457488-B1 | Intermediates for use in the preparation of urea compounds having muscarinic receptor antagonist activity | THERAVANCE INC (US) | 2009-08-12 | — | — | EP | disclosed |
| US-20090111737-A1 | Novel antibacterial agents | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2009-04-30 | — | — | US | disclosed |
| US-20090111737-A1 | Novel antibacterial agents | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2009-04-30 | — | — | US | disclosed |
| US-7456203-B2 | Muscarinic receptor antagonists | THERAVANCE, INC. (US) | 2008-11-25 | — | — | US | disclosed |
| US-7456203-B2 | Muscarinic receptor antagonists | THERAVANCE, INC. (US) | 2008-11-25 | — | — | US | disclosed |
| EP-1404687-A4 | FLUOROUS TRIPHASE AND OTHER MULTIPHASE SYSTEMS | UNIV PITTSBURGH (US) | 2004-10-27 | — | — | EP | disclosed |
| US-20040087820-A1 | Catalytic oxidation of C-H bonds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-05-06 | — | — | US | disclosed |
| EP-1404687-A2 | FLUOROUS TRIPHASE AND OTHER MULTIPHASE SYSTEMS | UNIVERSITY OF PITTSBURGH (US) | 2004-04-07 | — | — | EP | disclosed |
| US-20030125590-A1 | Fluorous triphase and other multiphase systems | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-07-03 | — | — | US | disclosed |
| WO-2002100802-A2 | FLUOROUS TRIPHASE AND OTHER MULTIPHASE SYSTEMS | UNIVERSITY OF PITTSBURGH (US) | 2002-12-19 | — | — | WO | disclosed |
| US-5407783-A | Thermostability, shelf life | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-04-18 | — | — | US | disclosed |
| JP-H01261354-A | PRODUCTION OF 2-CYCLOHEXEN-1-AMINE | SUMITOMO CHEM CO LTD | 1989-10-18 | — | — | JP | disclosed |
| US-4567195-A | Azaprostacyclins, their preparation and pharmaceutical use | SCHERING, AKTIENGESELLSCHAFT (DE) | 1986-01-28 | — | — | US | disclosed |
| US-4446147-A | Azaprostacyclins, their preparation and pharmaceutical use | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-05-01 | — | — | US | disclosed |
| EP-0059158-A2 | Aza prostacyclins, their preparation and therapeutic applications | SCHERING AKTIENGESELLSCHAFT (DE) | 1982-09-01 | — | — | EP | disclosed |